Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 27.10
+0.95 (3.63%)
Mar 26, 2026, 1:57 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.62 billion as of March 26, 2026. Its market cap has increased by 48.57% in one year.
Market Cap
2.62B
Enterprise Value
2.50B
Revenue
849.51M
Ranking
n/a
PE Ratio
20.30
Stock Price
27.10
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.62B, an increase of 105.40%. That is a compound annual growth rate of 4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 2.62B | 17.75% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 5.24B |
| Easywell Biomedicals | 4.84B |
| Orient EuroPharma | 4.00B |
| Merdury Biopharmaceutical | 3.35B |
| Maywufa Company | 2.90B |
| PhytoHealth | 2.57B |
| Johnson Chemical Pharmaceutical Works | 2.45B |
| TSH Biopharm Corporation | 1.95B |